A composite analysis of 8 cardiovascular outcomes trials completed in 2021 demonstrated reduced incidence of major cardiovascular events by 14% and cardiovascular death by 13% (NCT01147250, NCT01179048, NCT01720446, NCT01144338, NCT02465515, NCT01394952, NCT02692716, NCT03496298)
Pricing, product formulation, guarantee terms, shipping policies, and availability are subject to change at any time without notice
Figure 3 is a summarized version of the recommendations from both guidelines
Mol Cell Endocrinol 515:110921 Pang Y, Yuan X, Guo J, Wang X, Yang M, Zhu J, Wang J (2019) The effect of liraglutide on the proliferation, migration, and osteogenic differentiation of human periodontal ligament cells